The comparison between patients with and without Covid-19, exposed in both cases to surgery, revealed a higher incidence of complications and mortality in patients with COVID-19. A study coordinated by the Directors of Surgery of the University of Brescia and of the ASST-Spedali Civili assessed the first surgical outcomes of Covid-19 patients hospitalized at the […]
Covid-19 patients: additional surgical risk Leggi tutto »
In a study directed and coordinated by the Department of Information Engineering and the Department of Medical-Surgical Specialties, Radiological Sciences and Public Health of the University of Brescia, a group of researchers studied, for the first time internationally, the prognostic capacity of the Artificial Intelligence techniques (Deep Learning and Computer Vision) starting from the analysis
The city of Shenzen donates a tool for molecular diagnostics to the Microbiology and Virology Laboratory of the University of Brescia at Spedali Civili, directed by prof. Arnaldo Caruso. A gift that testifies the link between Brescia, the local Chinese community and China. The equipment arrived at the Civil and was immediately sent to the
The University of Brescia once again at the forefront of the battle against Coronavirus: the Industrial Control Systems research group of the Department of Mechanical and Industrial Engineering has been involved in the international Milan Mechanical Fan (MVM) project for development of new low-cost and fast production ventilators, aimed at being used by the greatest
A study conducted by prof. Marco Metra of the University of Brescia, Director of the Cardiology Unit of ASST-Spedali Civili, describes, for the first time, in the world literature, the demographic data, the clinical characteristics and the prognosis of cardiac Covid-19 patients and compares these data with those of patients without concomitant heart disease. All
In a study directed and coordinated by a group of specialists in Anesthesia and Intensive Care, Infectious Diseases, Rheumatology, Pediatrics, Clinical Biochemistry and Immunology of the University of Brescia (COMETA group – acronym for COVID-MEdiated hyper-inflammaTory stAte) were the evidence of the treatment with Tocilizumab, the drug currently in use for the treatment of some
![[pt_view id="56d7d9e74r"]](https://ricerca2.unibs.it/wp-content/uploads/2020/03/COVID.jpg)
Università degli Studi di Brescia and I.S.E.O. collaborate for the project “Nobels, Economists and Scientists for Covid-19”: a gathering of articles, essays and short videos by Nobel Laureates in Economics, economists and scientists from all over the world willing to give their contribute to comprehend what effects the Covid-19 spread will have on our lives
Due to the “precious and extraordinary scientific contribution made to date“, prof. Francesco Castelli, Professor of Infectious Diseases of the University of Brescia and Director of the School of Specialization in Infectious Diseases, was invited to take part in the Covid-19 Technical Scientific Committee, established by the Lombardy Region with Decree no. 4663 of 17/04/2020
The “Vademecum for the treatment of people with COVID-19 disease” was prepared by the Lombard section of SIMIT – Italian Society of Infectious and Tropical Diseases with the aim of supporting clinicians in therapeutic decisions. Involved in the definition of the document, within the «Collaborative Group – COVID-19 Lombardy Therapy» made up of 46 specialists
An important success for the Microbiology and Virology Laboratory of the University of Brescia. The team of researchers of prof. Arnaldo Caruso, who is the director of the Laboratory at the Civil Hospital of Brescia and President of the Italian Society of Virology, has isolated the Coronavirus strain (SarsCoV2) which has infected a patient from
